MEI Pharma Inc (NASDAQ:MEIP): Hedge Funds In Wait-and-See Mode
Does MEI Pharma Inc (NASDAQ:MEIP) represent a good buying opportunity at the moment? Let’s quickly check the hedge fund interest towards the company.
Mei Pharma Inc. (MEIP)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
Is MEI Pharma Inc (MEIP) A Good Stock To Buy?
You probably know from experience that there is not as much information on small-cap companies as there is on large companies.
How MEI Pharma Inc (MEIP) Stacks Up Against Its Peers
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
Hedge Funds Lay Out Bullish Cases for Tyson Foods, Credit Acceptance Corp, and More
Given that the third quarter is in the rear view mirror, a number of elite funds have released their latest investor letters.
Trading Week Kicks Off With A Bang for Wal-Mart and 4 Other Stocks
Disappointing trade figures out of China have investors on edge this morning as the trading week kicks off.
Why Are These Stocks Surging Today?
At a time when all three indices are in the red in anticipation of a Federal Reserve interest rate hike later in the month, shares of Keurig Green Mountain Inc (NASDAQ:GMCR), Sodastream International ...
Baker Bros. Advisors Reduces Exposure to MEI Pharma Inc (MEIP) to 3.4%
Julian and Felix Baker's Baker Bros. Advisors has decreased its stake in MEI Pharma Inc (NASDAQ:MEIP) to 746,521 shares, from 1,130,317 shares revealed as held earlier.
Baker Bros. Advisors Sells Some MEI Pharma, Discloses a Massive Stake in Mirati Therapeutics
In a couple 13D filings with the SEC, Julian and Felix Baker's Baker Bros. Advisors reported a 19.9% stake in Mirati Therapeutics, Inc.
Deerfield Management Reports Holding 6.38% of MEI Pharma
In a new 13G filing, James E. Flynn and his fund Deerfield Management reported a position in MEI Pharma Inc (NASDAQ:MEIP), which represents 6.38% of the company.
Jacob Gottlieb's Hedge Fund Buys a 5.4% Stake of MEI Pharma
Jacob Gottlieb, MEI Pharma: A couple of minutes ago, Jacob Gottlieb's hedge fund Visium Asset Management reported initiating a new position in MEI Pharma Inc (NASDAQ:MEIP).
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
